Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This notice reports an extension of a Phase 3 trial comparing vildagliptin with metformin in drug-naive adults with Type 2 diabetes to assess efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED